Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 13

Results For "Score"

931 News Found

Novartis CEO Vas Narasimhan joins Anthropic board
People | April 20, 2026

Novartis CEO Vas Narasimhan joins Anthropic board

Narasimhan’s appointment underscores the growing importance of AI in transforming drug discovery


Lupin subsidiary settles US antitrust case with Humana for $30 Million
News | April 20, 2026

Lupin subsidiary settles US antitrust case with Humana for $30 Million

The litigation involved multiple civil lawsuits alleging anti-competitive practices and violations of federal


Health Prime appoints Nidhi Bajaj as Vice President – Human Resources
People | April 20, 2026

Health Prime appoints Nidhi Bajaj as Vice President – Human Resources

Bajaj joins Health Prime after a long and progressive tenure at Concentrix


Apollo Hospitals appoints Dr Harit Kumar Chaturvedi as CEO
People | April 20, 2026

Apollo Hospitals appoints Dr Harit Kumar Chaturvedi as CEO

Move to accelerate cancer care expansion across India


NHA convenes Chintan Shivir to accelerate Ayushman Bharat schemes
Policy | April 18, 2026

NHA convenes Chintan Shivir to accelerate Ayushman Bharat schemes

Focus on preventive, tech-driven healthcare and digital ecosystem reforms under AB PM-JAY and ABDM


ANRF CEO calls for excellence-led innovation at SRMIST Research Day
R&D | April 18, 2026

ANRF CEO calls for excellence-led innovation at SRMIST Research Day

Dr Shivkumar Kalyanaraman emphasizes need for quality research, partnerships, and measurable outcomes


Indian Pharmacopoeia 2026 highlights need for stronger drug standards and global alignment
Policy | April 18, 2026

Indian Pharmacopoeia 2026 highlights need for stronger drug standards and global alignment

Experts highlighted that robust pharmacopoeial frameworks are essential for maintaining the quality, safety and efficacy of medicines


Revvity aims to accelerate breakthroughs in cancer research
R&D | April 17, 2026

Revvity aims to accelerate breakthroughs in cancer research

Revvity is positioning its technologies as a connected engine for discovery


Bayer flags major Phase III results for stroke prevention drug asundexian
Clinical Trials | April 17, 2026

Bayer flags major Phase III results for stroke prevention drug asundexian

The study evaluated asundexian (50 mg), a once-daily oral anticoagulant candidate, versus placebo—both given alongside standard antiplatelet therapy


NIFTY Pharma shows stable trend amid cautious market sentiment
News | April 17, 2026

NIFTY Pharma shows stable trend amid cautious market sentiment

Muted movement reflects consolidation phase as investors await earnings triggers